Tag - NNOX

Developments

FDA grants clearance for Nanox.ARC expanding application to pulmonary and general use

Nanox Imaging (NASDAQ:NNOX) has announced that its Nanox.ARC stationary X-ray system has received 510(k) clearance from the FDA, allowing general use including the human musculoskeletal system, pulmonary, intra...

December 6, 2024

Markets

AGP starts Nano-X Imaging at buy; PT $14.50

Alliance Global Partners initiated coverage of Nano-X Imaging (NASDAQ:NNOX) with a “buy” rating and price target of $14.50. The stock closed at $7.66 on Sept. 7. “Nano-X’s novel digital X-ray source has the potential to...

September 8, 2023

Markets

Cantor resumes coverage of Nano-X Imaging at OW; PT $21

Cantor Fitzgerald resumed coverage of Nano-X Imaging (NASDAQ:NNOX) with an “overweight” rating and 12-month price target of $21 after attending the company’s ARC Day in Israel. The stock closed at $7.60 on Jan. 4. The...

January 5, 2023

Tag - NNOX

FDA grants clearance for Nanox.ARC expanding application to pulmonary and general use

AGP starts Nano-X Imaging at buy; PT $14.50

Cantor resumes coverage of Nano-X Imaging at OW; PT $21

General

More